These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25659145)
1. UFSRAT: Ultra-fast Shape Recognition with Atom Types--the discovery of novel bioactive small molecular scaffolds for FKBP12 and 11βHSD1. Shave S; Blackburn EA; Adie J; Houston DR; Auer M; Webster SP; Taylor P; Walkinshaw MD PLoS One; 2015; 10(2):e0116570. PubMed ID: 25659145 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of Liu Z; Singh SB; Zheng Y; Lindblom P; Tice C; Dong C; Zhuang L; Zhao Y; Kruk BA; Lala D; Claremon DA; McGeehan GM; Gregg RD; Cain R J Chem Inf Model; 2019 Aug; 59(8):3422-3436. PubMed ID: 31355641 [TBL] [Abstract][Full Text] [Related]
3. Correction: UFSRAT: Ultra-Fast Shape Recognition with Atom Types--the discovery of novel bioactive small molecular scaffolds for FKBP12 and 11βHSD1. PLOS ONE Staff PLoS One; 2015; 10(3):e0122658. PubMed ID: 25768114 [No Abstract] [Full Text] [Related]
4. Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening. Xia G; Xue M; Liu L; Yu J; Liu H; Li P; Wang J; Li Y; Xiong B; Shen J Bioorg Med Chem Lett; 2011 Oct; 21(19):5739-44. PubMed ID: 21873057 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling. Yang H; Dou W; Lou J; Leng Y; Shen J Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors. Miguet L; Zhang Z; Barbier M; Grigorov MG J Comput Aided Mol Des; 2006 Feb; 20(2):67-81. PubMed ID: 16783599 [TBL] [Abstract][Full Text] [Related]
7. Identification of important chemical features of 11β-hydroxysteroid dehydrogenase type1 inhibitors: application of ligand based virtual screening and density functional theory. Sakkiah S; Meganathan C; Sohn YS; Namadevan S; Lee KW Int J Mol Sci; 2012; 13(4):5138-5162. PubMed ID: 22606035 [TBL] [Abstract][Full Text] [Related]
8. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980 [TBL] [Abstract][Full Text] [Related]
9. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors. Lee JH; Kang NS; Yoo SE Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331 [TBL] [Abstract][Full Text] [Related]
10. A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1. Studzińska R; Kołodziejska R; Kupczyk D; Płaziński W; Kosmalski T Bioorg Chem; 2018 Sep; 79():115-121. PubMed ID: 29738970 [TBL] [Abstract][Full Text] [Related]
11. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational Modeling. Liu H; Li L; Zhang C; Li H; Liu J; Tang C; Zhang Y; Wu D; Chu Y; Wu Y; Yuan X Pharmacology; 2018; 102(3-4):169-179. PubMed ID: 30099452 [TBL] [Abstract][Full Text] [Related]